Avion Pharmaceuticals Revenue and Competitors

Atlanta, GA USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Avion Pharmaceuticals's estimated annual revenue is currently $27.7M per year.(i)
  • Avion Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Avion Pharmaceuticals has 138 Employees.(i)
  • Avion Pharmaceuticals grew their employee count by -30% last year.

Avion Pharmaceuticals's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP Market AccessReveal Email/Phone
3
VP SalesReveal Email/Phone
4
VP Trade Sales & Professional DevelopmentReveal Email/Phone
5
VP MarketingReveal Email/Phone
6
VP Marketing, Specialty TherapeuticsReveal Email/Phone
7
Head Sales, NeurologyReveal Email/Phone
8
National Account DirectorReveal Email/Phone
9
Associate Director - AnalyticsReveal Email/Phone
10
Executive Territory ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$24.5M1228%N/AN/A
#2
$10.7M53-17%N/AN/A
#3
$9.2M462%N/AN/A
#4
$24.1M1205%N/AN/A
#5
$7.2M36-20%N/AN/A
#6
$27.7M138-30%N/AN/A
#7
$39.8M19837%N/AN/A
#8
$0.5M525%$50MN/A
#9
$13.7M68-7%N/AN/A
#10
$10.3M5111%N/AN/A
Add Company

What Is Avion Pharmaceuticals?

Avion is a Specialty Pharmaceutical company that develops and markets a growing portfolio of innovative, branded prescription pharmaceutical and dietary supplement products in Women's Health, Dermatology, Hematology, and related Specialties. Avion focuses on identifying opportunities to acquire and enhance the market potential of innovative, commercially available dietary supplements, therapeutics and late-stage development products to fulfill unmet medical and dietary needs.

keywords:N/A

N/A

Total Funding

138

Number of Employees

$27.7M

Revenue (est)

-30%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Avion Pharmaceuticals News

2022-04-17 - Global Pericarditis Drugs Market 2022 Report Development ...

Takeda Pharmaceuticals Industries Ltd; Teva Pharmaceutical Industries Ltd; Merck & Co. Inc; Abbive(Allergan); Hikma Pharmaceuticals PLC; Avion...

2022-04-13 - ImmuPharma shares jump on lupus study data

Avion Pharmaceuticals, ImmuPharma's US partner, has played a key part in the development, initiation and successful conclusion of this PK...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$75M13972%N/A
#2
$22.2M1391%N/A
#3
$15M140N/AN/A
#4
$22.3M1401%N/A
#5
$32.3M1402%N/A